Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials
It can be difficult to consistently obtain all necessary nutrients through diet alone
Shirley, an 82-year-old man, was prescribed Ozempic in 2022
Jatoi S, Hafeez A, Riaz SU, Ali A, Ghauri MI, Zehra M
Standard overnight fasting alone is not sufficient for GLP-1 users due to slowed gastric emptying
Studies, including the MASALA study on South Asian immigrants in America, highlight the particularly high susceptibility of South Asians to these conditions